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The experiments described in an accompanying paper (1) were con- 
ducted in an effort to determine the factors involved in the develop- 
ment  of  heterologous  neutralizing  antibodies  by  various  animals, 
following  immunization  or  infection  with  the  viruses  of  swine  and 
human  influenza.  It was  found that,  while  both human  and  swine 
influenza  viruses  were  neutralized  consistently  by  their homologous 
immune sera, the sera from animals convalescent from a  single infec- 
tion with one virus possessed little, if any, neutralizing capacity for the 
other.  Repeated exposures of the animals  to either virus, but espe- 
dally  that  of human  influenza,  tended  to  increase  the  heterologous 
neutralizing activity of their sera. 
In a second paper (2) the neutralizing action of sera from a group of 
human subjects of various ages on human influenza virus was reported. 
The present paper deals with the ability of these same sera to neutral- 
ize swine influenza virus, and the results will be compared with those 
of the preceding paper in an attempt to determine the relation of the 
swine virus to disease in man. 
The strain 15 swine influenza virus was used in all of the present experiments. 
It was obtained originally through the kindness of Dr. Fred Crow from a case of 
the swine disease occurring in Iowa in December, 1930.  The sources of the human 
sera employed have been given in the preceding paper.  11 of the 137 sera ob- 
tained  were  tested  against  human  but  not  swine  virus.  2  more  sera,  found 
satisfactory for use by the technique of inoculation employed by Francis and 
Magill  (2) proved toxic for mice by the method used in this laboratory.  1 serum 
was tested against swine but not human influenza virus.  The remaining  123 sera 
were tested for their ability to neutralize both human and swine virus and these 
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form the basis for the present paper.  It is realized  that  the  number  of  sera 
studied is small statistically and that gaps exist in certain important age groups. 
Neutralization Tests 
The neutralization tests were performed as previously described for swine in- 
fluenza virus (1).  The supernatant of a 2 per cent suspension of glycerolated in- 
fected mouse lung was used as the source of virus and mixed with an equal amount 
of each serum to be tested.  The period of storage of the mixtures, the method of 
their administration to mice, and the criteria for judging the neutralizing effect 
of sera of unknown potency were the same as already described (1).  The amount 
of swine virus administered to each mouse in each serum-virus mixture was suffi- 
cient to kill all or most of the control mice within the 6 day period that each test was 
allowed to run.  At the end of 6 days all surviving mice were killed with chloro- 
form, and the extent of their pulmonary lesions recorded.  These lesions and those 
of mice which died earlier were graded from 4+  for lungs exhibiting a  complete 
influenza virus pneumonia, to 0 for those whose lungs were free of influenza lesions. 
The basis upon which the final result of each test was determined and upon which 
the degree of protection afforded by each serum was graded has been described in 
the preceding paper (2).  Mice 3 to 5 weeks old and weighing from 10 to 15 gin. 
were used. 
The  results of  experiments  in  which  human  sera  were  tested  for 
their ability to neutralize swine influenza  virus are showri in Table I. 
Consideration of the data given in Table I  and presented graphically in Text- 
fig. 1 shows that the sera of infants between the ages of 3 days and 1 month con- 
sistently neutralized swine virus.  These results are in agreement with those with 
sera from individuals of the age group of the mothers of the infants and may be 
explained as probably due to maternal transfer of neutralizing antibodies.  The 
sera of babies from 2 to 9 months of age, on the other hand, failed to neutralize 
swine influenza virus.  1 of the 14 sera from children between the ages of 1 and 5 
years and 2 of the 8 from children 6 to 9 years old neutralized the virus of swine 
influenza completely or almost completely.  Others of these age groups showed 
evidence of possessing small amounts of neutralizing antibodies and these will be 
discussed in more detail later.  Of 7 sera from children between the ages of 10 
and 12 years, 4 neutralized swine influenza virus completely or almost completely. 
Those from persons in the higher age groups, from 21 years on, with very few ex- 
ceptions, neutralized the virus of swine influenza.  The results of these experi- 
ments  are  in  striking agreement  with  those  published recently by  Andrewes, 
Laidlaw, and Smith (3). 
The curve in Text-fig. 1 representing the ability of sera from human beings to 
neutralize swine influenza virus rose steadily with advancing age to reach a peak 
of 100 per cent for the sera from persons in the 30 to 39 year age group.  It de- TABLE  I 
Neutralization  Tests with Swine Influenza  Virus and Sera of Human Beings  of 
Various Ages 
Serum No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
Age of donor 
days 
3 
4 
5 
6 
6 
7 
7 
8 
10 
11 
14 
tWOS. 
1 
1 
2 
2 
3 
8 
9 
9 
13 
13½ 
Serum-vlrus mixture administered intranasally to mice 
Pulmonary lesions 
Mouse  No. 
1  2  3  4 
O* 
0 
0 
0 
0 
0 
0 
0 
2,1, 
0 
0 
3+ 
44-~ 
4-1,~ 
4-1. 
4,1, 
2,1, 
2+ 
0 
0 
0 
2+ 
0 
0 
0 
0 
0 
0 
0 
0 
Toxic 
3,1, 
4-t-$ 
4-1,~ 
4+ 
4-1. 
3,1, 
3+ 
0  0 
2,1,  0 
0  0 
0  2,1. 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
2,1. 
4+~ 
4,1,~  4,1,~ 
4+ 
4,1, 
2,1,  3,1. 
2,1.  2,1. 
Result 
Pt 
P 
P 
I 
P 
P 
P 
P 
P 
P 
P 
NP 
NP 
NP 
NP 
NP 
NP 
PP 
*0 
1+ 
postmortem. 
2,1-  =  mouse with influenzal pneumonia involving from ~  to ~  of 
postmortem. 
3,1.  =  mouse with influenzal pneumonia involving from ~  to a~  of 
postmortem. 
4,1.  =  mouse  with influenzal pneumonia involving from ~  to all of 
postmortem. 
t  P  =  complete protection--serum neutralized the virus. 
I  =  incomplete protection--serum exerted considerable neutralizing effect 
on virus but failed to protect completely. 
PP  =  partial protection--serum exerted slight neutralizing effect on the virus. 
NP  =  no protection--serum failed completely to neutralize the virus. 
~:  =  mouse died. 
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=  mouse with no detectable influenzal lesions postmortem. 
=  mouse with  influenzal pneumonia  involving upwards  to ~  of lung at 
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TABLE  I--Contlnued 
Serum No. 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
5O 
51 
52 
53 
54 
55 
56 
57 
58 
59 
6O 
Age of donor 
l½ 
2½ 
3 
3 
3 
3 
3 
3 
3 
3 
3 
4 
5 
6 
6 
6½ 
7 
7 
8 
9 
9 
9 
9 
10 
10 
I0 
11 
i1 
12 
12 
12 
15 
18 
18 
19 
21 
22 
22 
23 
Serum-virus mixture administered intranasally to mice 
Pulmonary lesions 
Mouse No. 
4+++ 
4+~ 
4+++ 
3+ 
4+++ 
2+ 
2+ 
2+ 
4+~ 
2+ 
4+~ 
2+ 
l+ 
4+5 
3+ 
2+ 
2+ 
2+ 
4+~ 
0 
4+~ 
2+ 
3+ 
4- 
0 
4- 
4+~ 
0 
0 
0 
4+++ 
4+++ 
4+~ 
3+ 
4+5 
0 
2+ 
3+ 
4+++ 
3+ 
4+++ 
1+ 
0 
3+ 
2+ 
i+ 
l+ 
2+ 
4+~ 
1+ 
4+~ 
2+ 
3+ 
0 
0 
0 
1+ 
0 
0 
0 
4+++ 
4+++ 
4+~ 
3+ 
4+++ 
2+ 
3+ 
2+ 
2+ 
2+ 
4+++ 
2+ 
0 
3+ 
2+ 
0 
2+ 
l+ 
4+~ 
0 
4+~ 
2+ 
3+ 
0 
-4- 
1+ 
3+ 
0 
2+ 
0 
4++  + 
4+++ 
4+5 
2+ 
3+ 
0 
2+ 
2+ 
4+ 
2+ 
4+++ 
1+ 
0 
l+ 
1+ 
1+ 
2+ 
4+ 
1+ 
3+ 
2+ 
:t: 
0 
2+ 
3+ 
1+ 
0 
Result 
NP 
NP 
NP 
NP 
NP 
I 
PP 
PP 
NP 
PP 
NP 
PP 
P 
NP 
PP 
PP 
PP 
PP 
NP 
I 
NP 
PP 
NP 
I 
P 
I 
NP 
P 
I 
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TABLE  I--Continued 
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Serum-virus mixture administered intranasally to mice 
Pulmonary lesions 
Mouse No. 
Serum No. 
61 
62 
63 
64 
65 
66 
67 
68 
69 
70 
71 
72 
73 
74 
75 
76 
77 
78 
79 
80 
81 
82 
83 
84 
85 
86 
87 
88 
89 
90 
91 
92 
93 
9,t 
95 
96 
97 
98 
99 
Age of donor 
yrs. 
24 
24 
25 
25 
25 
26 
26 
27 
27 
27 
27 
28 
28 
28 
30 
30 
30 
30 
31 
31 
31 
31 
31 
32 
32 
32 
33 
33 
34 
34 
34 
34 
34 
35 
36 
36 
37 
4O 
42 
± 
0 
0 
0 
0 
1+ 
± 
0 
0 
0 
0 
0 
0 
1+ 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
2  3  4 
0  0  1+ 
1+  0  0 
0  1+  0 
2+  0  0 
0  0 
1+  0  2+ 
0  ±  1+ 
0  0  1+ 
1+  0  0 
0  0  0 
0 
1+ 
l+ 
0 
0 
0 
0 
0 
0 
0 
0 
2+ 
.-t- 
O 
0 
0 
0 
0 
0 
0 
1+ 
0 
0 
0 
0 
0 
0  0 
±  1+ 
0 
0  2+ 
0  0 
0  0 
0  0 
1+  0 
0  1+ 
0  0 
0  0 
l+ 
1+  1+ 
0 
0  0 
0 
0 
0  0 
0 
0  0 
1+  0 
0  1+ 
0  0 
0  0 
0 
0  0 
0  0 
Result 
I 
P 
P 
P 
P 
PP 
PP 
P 
P 
P 
P 
I 
I 
I 
P 
P 
P 
P 
P 
P 
P 
I 
I 
P 
P 
P 
P 
P 
P 
P 
I 
P 
P 
P 
P 
P 674  ANTIBODIES  ]FOR  SWINE  INFLUENZA  IN  HUMAN  SERA 
TABLE  I--Concluded 
Serum No. 
100 
101 
102 
103 
104 
105 
106 
107 
108 
109 
110 
111 
112 
113 
114 
115 
116 
117 
118 
119 
120 
121 
122 
123 
124 
125 
126 
127 
128 
129 
130 
131 
132 
133 
134 
135 
136 
137 
Serum-virus  mixture administered  intrsnasally  to  mice 
Pulmonary  lesions 
Mouse No. 
Age of donor 
42 
43 
2  3 
0  0 
0  0 
0 
4- 
44 
45 
45 
46 
46 
46 
46 
47 
47 
47 
48 
0 
0 
0 
0 
0 
0 
0 
2+ 
0 
0 
1+ 
1+ 
0 
0 
0 
1+ 
0 
0 
0 
0 
0 
2+ 
0 
0 
0 
0 
1--I- 
0 
0 
2+  2+ 
1+ 
0 
0 
0 
1+ 
1+ 
0 
0 
49 
50 
50 
50 
51 
52 
52 
53 
53 
54 
56 
57 
58 
58 
59 
6O 
6O 
64 
65 
65 
66 
70 
70+ 
73 
76 
2+ 
0 
0 
0 
1+ 
0 
0 
0 
0 
0 
0 
0 
0 
2+ 
0 
0 
0 
0 
0 
0 
0 
0 
1+ 
1+ 
0 
0 
0 
1+ 
0 
0 
1-1- 
0 
0 
0 
0 
0 
1+ 
0 
0 
0 
0 
0 
0 
24- 
0 
Toxic 
1+ 
0 
-4- 
0 
0 
1+ 
0 
0 
0 
0 
0 
0 
0 
1+ 
0 
0 
2+ 
0 
0 
0 
0 
0 
1+ 
0 
d 
0 
0 
0 
0 
0 
0 
1-{- 
2-1- 
Result 
P 
P 
I 
I 
P 
P 
P 
I 
P 
I 
P 
P 
PP 
PP 
P 
P 
P 
I 
P 
P 
P 
P 
P 
P 
P 
P 
PP 
P 
P 
P 
P 
P 
P 
P 
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TExT-Fzo. 2.  Degree of neutralizing activity of sera from persons of various 
ages for swine influenza virus in mice.  Each dot represents a virus neutralization 
test with serum from one person. 
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T~xT-FzG. 1.  Percentage of persons of various ages whose sera neutralize the 
virus of swine influenza.  For the purposes of this chart sera which give incom- 
plete (see Table I) as well as complete protection are included. 
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dined slightly in age groups of the next two decades but this is of doubtful signifi- 
cance, since the 3 sera responsible for the decline all partially neutralized the virus. 
Text-fig. 2 shows the neutralizing activity for swine influenza virus of sera from 
persons in the various age groups.  The results recorded below the double line 
have been included  in Text-fig.  1 and need no further discussion.  Those above 
the double line represent results with human sera that either failed to neutralize 
swine virus or neutralized it only partially.  The chart shows that most of the 
non-neutralizing  sera were from persons less than 20 years of age.  The serum of 
only 1 person above 20 years of age failed completely to neutralize the virus, while 
5 others are recorded as partially neutralizing it. 
Correlation of Past History of Influenza with Presence of Swine Influenza 
Virus-Neutralizing Antibodies 
74 persons over the age of 12 years recorded in Table I  were ques- 
tioned  as  to  their past  influenza history.  The  sera of 44 out of 45 
(97.7 per cent) of those giving a positive history of influenza neutralized 
the  virus  of  swine  influenza.  17  of  those  possessing  a  neutralizing 
serum gave as the date of their illness a  time between 1918 and 1923, 
12 between 1930 and 1935, and 5 had influenza both in 1918 and early 
in  1930.  10  were  certain of having had  an  attack  of influenza but 
were indefinite concerning the date;  the  1 person giving a  history of 
influenza whose serum failed to neutralize the virus of swine influenza 
fell in this group.  29 persons stated that to the best of their knowledge 
they had never had influenza.  The sera of 25 of these (86.2 per cent), 
however, neutralized swine virus.  Since it is realized that histories of 
influenza outside  of pandemic  periods  are  not  accurate,  the  figures 
outlined above are believed to be of little significance. 
Correlation of Age of Serum Donor with the Presence of Neutralizing 
Antibodies for Swine Influenza Virus 
Of the individuals recorded in Table I, excepting the infants 1 month 
of age or younger, the sera of only 4 of 31 of those under 12 years of 
age neutralized the swine virus, whereas only 6 of 81 of those 12 years 
of age or older failed to do so.  The possible significance of the corre- 
lation between age  and  the possession of neutralizing antibodies  for 
swine influenza virus will be considered later.  It is of interest that 
Andrewes, Laidlaw, and Smith  (3), in their neutralization tests with 
English sera and swine virus found that none of their sera from per- 
sons under 10 years of age neutralized the virus. RICHARD  E.  SHOPE  677 
Comparison of the Ability of Human Sera to Neutralize  the  Viruses 
o] Human and Swine Influenza 
There can be no doubt from the work of Smith,  Andrewes, and 
Laidlaw  (4)  that  the  sera  of persons  convalescent from influenza 
neutralize their strains of the human virus.  The value of the neutral- 
ization test as an indicator of the type of virus involved in previous 
human infections is suggested by its specificity in animal infections of 
known type (1, 4, 5, 6).  However, it remained for Francis and Magill 
(7) to demonstrate conclusively that man actually develops antibodies 
neutralizing human virus following  an attack of the disease.  They 
found that the sera of 3 persons, bled during the acute stage of an 
attack of influenza, failed to neutralize the P. R. 8 strain of the virus of 
human influenza, whereas that obtained during their convalescence 
and again 6 months later did neutralize the virus. 
The presence of antibodies in human sera capable of neutralizing 
swine influenza virus is more difficult to interpret because no strain of 
influenza virus,  immunologically identical with  that  obtained from 
swine, has been recovered from man.  A possible explanation for the 
presence of these antibodies in such a large proportion of the adult 
sera examined is  afforded by the  experiments recorded in  the first 
paper of this series  (1).  It was shown that while serum of animals 
convalescent from a single infection with the virus of human influenza 
possessed  little, if any, ability to neutralize swine virus, serum from 
animals submitted to repeated exposures to human virus was capable 
of partially or completely neutralizing swine  virus.  These findings 
suggested the possibility that the neutralizing properties of human sera 
for swine virus might be the result of repeated exposures to the virus 
of human influenza.  The fact that sera from adults neutralized swine 
virus much more frequently than that from children was in  accord 
with this possibility; conceivably the more advanced the age of the 
person the more numerous had been his opportunities for exposure to 
the virus of the human disease.  The results of the neutralization test 
with swine  virus alone are not sufficient  to exclude this possibility. 
However, when the results of duplicate neutralization tests against the 
viruses of both human and swine  influenza were compared, it was 
evident that, in a number of instances at least, neutralization of swine 
virus could not be considered the result of repeated exposures to the 678  ANTIBODIES  l~OR  SWINE  INI~LU'ENZA  IN  HUMAN  SERA 
human virus.  The sera from 35 persons in the group studied neutral- 
ized the swine virus completely but failed to neutralize that of human 
influenza (see Table II).  If, in these 35 cases, the ability to neutralize 
swine virus had been the result of repeated infections with the virus 
of human influenza, it would be anticipated that the latter virus would 
have been neutralized also by the sera.  The facts lead one to ~ask 
whether the human donors of sera which neutralized swine virus only 
had not undergone a previous infection with a virus of this sort. 
The results obtained in the present study of swine virus have been 
compared with those described by Francis and Magill (2)  for human 
virus, in order better to evaluate their significance.  This comparison 
is outlined in Table II.  An interpretation of the findings, on the basis 
of the cross-neutralization experiments with sera from animals known 
to be immune to swine or human influenza virus (1), is also included. 
As will be seen in Table II, the sera from only 9 persons, all under 7 
years of age (group 1),  failed entirely to neutralize either human or 
swine influenza virus.  The sera from 6 persons (group 2), all under 
12 years of age, neutralized the virus of human influenza but not that 
of swine influenza.  The sera of another group of 5 persons (group 3), 
all under 8 years of age, neutralized human virus completely and also 
exerted a  slight neutralizing effect upon swine virus.  The sera from 
11 persons (group 4), all, with the exception of one new-born, over 24 
years of age, neutralized the virus of swine influenza but not that of 
human influenza.  The sera from another group of 24 persons (group 
5) neutralized swine virus completely and also exerted a slight neutral- 
izing effect on human virus.  18 of the members of this group were 
over 24 years of age, 4 were new-born, and the remaining 2 were 6 and 
12 years of age. 
The sera of 33 persons, listed in Table II as group 6,  completely 
neutralized the viruses of both human and swine influenza.  With the 
exception of 5 new-born and 1 child 9 years old, all of this group were 
18 years of age or older.  The general age distribution was thus the 
same as for those listed in groups 4 and 5 whose sera had neutralized 
only  swine  influenza  virus.  The  sera  of  9  persons,  designated  as 
group 7 in Table II, neutralized human influenza virus completely and 
also exerted considerable neutralizing effect on swine virus, while the 
sera of 4 others, designated as group 8, neutralized swine virus corn- RICHARD  E.  SHOPE  679 
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pletely and exerted considerable neutralizing effect on human virus. 
The sera from persons in the last three groups in Table II neutralized 
neither virus completely, but did partially protect against one or both 
of them. 
The comments on the possible significance of these data in indicating 
the type of virus involved in past influenzal infections of the persons 
studied, made in the last  column of Table  II,  are  self-explanatory. 
It is clear that antibodies neutralizing swine influenza virus are present 
in human sera and frequently independent of those effective against 
the human virus.  The most evident explanation of their presence is 
that they arose as a result of previous infection by a virus whose anti- 
genic composition was similar to that of swine influenza.  The high 
incidence of swine virus-neutralizing antibodies in  sera from adults 
and their rarity in sera from children further suggest that the agent 
responsible for their generation has not recently been widely prevalent. 
This will be more fully discussed later. 
DISCUSSION 
So far as the present studies are concerned, it has been found that 
the sera from a very high proportion of human adults neutralize swine 
influenza virus while those from children below the age of 12, with the 
exception of new-born infants, seldom exert such an effect.  On the 
surface, the situation would appear to be similar to that known for 
diphtheria, for instance, in which the serum antitoxin titer,  low in 
childhood, increases with advancing age.  To be entirely comparable, 
however, the causative agent, namely an influenza virus of an anti- 
genic composition similar to swine virus, should be rather widespread 
throughout the human population.  The viruses isolated from clinical 
cases of influenza in man during the past 2 years from such widely 
separated localities as London (5),  Puerto Rico (9),  Philadelphia (6), 
and Melbourne (10),  are immunologically identical (3, 6,  10).  Since 
the human virus differs immunologically from the swine virus (1, 3, 4, 
6),  its presence cannot be held accountable for the high incidence of 
antibodies for swine influenza virus encountered in sera from human 
adults.  Moreover, as has been pointed out earlier,  the  presence of 
such antibodies cannot be considered the result of repeated exposures 
to the current human type of virus, because the sera from 35 of the ~ICHARD ~.  SHOI'~.  681 
individuals studied neutralized swine virus but not human virus.  It 
seems  unlikely  that  the  age  distribution  of  antibodies  neutralizing 
swine influenza virus can be interpreted on the basis of frequency of 
opportunity for infection with a virus that  is at present widely preva- 
lent.  Furthermore,  the  age  distribution  of  antibodies  found  by 
Francis and Magill (2) for an influenza virus of human type known to 
be prevalent in man during the past 2 years is quite different from that 
for the virus of swine influenza. 
The history of swine influenza furnishes a clue to the interpretation 
of the neutralization  experiments under discussion.  The disease was 
first recognized as a clinical entity in the late summer or fall of 1918. ~ 
Conversations  with  veterinary  practitioners  in  eastern  Iowa  have 
revealed that the disease caused serious losses among swine on exhibi- 
tion  at  the  Cedar  Rapids  Swine  Show held  from  September  30  to 
October 5, 1918.  At the conclusion of the  show, the  swine, many of 
them ill, were returned to their home farms and, within 2 or 3 days of 
their return, influenza was stated to be rampant in the portion of the 
drove  that  had  remained  at  home.  Shortly  thereafter  the  disease 
became widespread among swine herds in Iowa and other parts of the 
Middle West.  It persisted in various localities until January of 1919. 
The epizootic in the autumn  and winter of 1919 was stated to be as 
extensive and severe as that in 1918.  The disease has appeared among 
swine in  the Middle West every year since but varies from  year to 
year in its severity and extent. 
According to Dorset, McBryde, and Niles (11), Dr. J. S. Koen, an 
Inspector in the Division of Hog Cholera  Control of the Bureau of 
Animal Industry, was the first to recognize the disease as being differ- 
ent  from  any previously encountered.  He was so  much  impressed 
by the coincidental prevalence of human influenza and by the resem- 
blance of the symptoms seen in man to those occurring at the time in 
hogs that he became convinced that the two were actually the same. 
He therefore gave the name of "flu" to this new disease of hogs.  The 
opinion  of  Koen  that  "flu"  represented  an  entirely  new  swine 
1  Dr. Grant B. Munger of Cedar Rapids, Iowa, has stated in a personal com- 
munication that he observed herds of swine ill with influenza as early as August 
of 1918 in western Illinois where he was then serving as an inspector in the Divi- 
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epizoofic disease, not seen before 1918, was shared by many veterinary 
practitioners in the Middle West.  Dimoch, in an exhaustive paper 
on  the differential diagnosis of  diseases of swine  (12)  presented in 
August,  1918, makes no mention of a  disease of swine bearing any 
resemblance to  influenza.  It  seems clear  that  swine influenza ap- 
peared in the Middle West as an epizootic disease for the first time, in 
recent years at least, during the late summer or early autumn of 1918. 
The new disease  thus made its  first  appearance at  a  time when 
human pandemic influenza was  at  its  height in  the  Middle West. 
Many thought that the two diseases were connected and that swine 
might have been infected in the first instance from human beings (13). 
Murray and Biester (14) have called attention to the similarity exist- 
ing between the "water logged" lung of the human influenzal pneu- 
monia of 1918  and that of the pneumonia of fatal swine influenza. 
The writer, in earlier work (15), was impressed not only by similarities 
between the clinical and pathological pictures of human and swine 
influenza but by the association of a  leucopenia with both diseases 
and, most especially, by the similarity of the predominant bacterium 
encountered in each disease: H. influenzae  in the epidemic disease of 
man and H. influenzae suis in the epizootic disease of swine.  On the 
basis of the similarities between the two diseases, after establishment 
of the fact that swine influenza was caused by the combined action of a 
filtrable virus and H. influenzae suis, it was suggested that an investiga- 
tion of the possibility that Pfeiffer's bacillus and a filtrable agent act in 
concert to cause influenza in man seemed indicated.  The possibility 
received support from the discovery by Smith, Andrewes, and Laidlaw 
(5) of a virus in cases of human influenza similar to that etiologically 
important in swine influenza, and Laidlaw (16) propounded the view 
that "the virus of swine influenza is really the virus of the great pan- 
demic of 1918, adapted to the pig and persisting in that species ever 
since." 
The ability of such a large proportion of the sera from human adults 
to neutralize the virus of swine influenza adds weight to the view that 
this virus or one of its antigenic composition has recently been widely 
prevalent in man.  The  similarity of swine influenza virus to  that 
etiologically important in recent influenza in man, with regard to its 
pathogenic activity in common experimental animals (5, 8, 9, 17, 18), RICHARD  E.  SHOPE  683 
further suggests that its past activity, so far as man may be concerned, 
lay in the production of influenza. 
All of these facts viewed as a whole make it necessary to consider 
seriously the theory that swine influenza virus represents a surviving 
form of the human pandemic virus of 1918, and that it has not had its 
immunological identity detectably altered by its prolonged sojourn 
in hogs.  On the basis of this assumption the presence in human sera 
of antibodies  neutralizing  the  swine  virus would be  considered as 
indicating that the donors of these sera had undergone an immunizing 
exposure to or infection with an influenza virus of the 1918 pandemic 
type. 
Andrewes, Laidlaw, and Smith (3)  in interpreting the significance 
of  their  neutralization  experiments  with  human  sera  obtained  in 
England, and the same strain of swine virus used in the present experi- 
ments (strain 15, Iowa, 1930) have guardedly suggested an explanation 
similar to that just outlined.  They have qualified their interpretation 
by considering the possibility that  the antibodies to swine virus in 
adult human sera may be non-specific in the sense that they represent 
past contact, not with  that virus,  but with some unknown related 
antigen. 
If swine influenza virus is actually a  surviving form of  the  1918 
human  pandemic strain,  then  two  inferences,  interesting  from  an 
epidemiological  standpoint,  become  apparent  immediately.  The 
first of these is that virus of the 1918 type has been present in human 
beings within the past 6 years, since the serum from one 6 year old 
child in the group tested neutralized the swine virus.  The second is 
that persons at present susceptible to virus of the 1918 type, as indi- 
cated by the failure of their sera to neutralize swine influenza virus, are 
limited largely to those in the lower age groups born since pandemic 
influenza ceased to be prevalent. 
SUMMARY 
Sera from a very high proportion of the human adults and new-born 
infants studied neutralized swine influenza virus; sera from children 
below the age of 12 years seldom exerted such an effect.  The results 
of neutralization experiments with human sera and the virus of swine 
influenza have been compared with the outcome of similar tests with 684  ANTIBODIES  FOR SWINE IN~'LU"gNZA IN  HUM.AN SERA 
the virus of human influenza, and it seems evident that the presence of 
antibodies neutralizing  swine influenza  virus  cannot  be deemed  the 
result of repeated exposures to the current human type of virus.  From 
the known history of swine influenza and the similarity of its etiologic 
virus to that obtained from man it seems likely that the virus of swine 
influenza is the surviving prototype of the agent primarily responsible 
for the great human  pandemic of 1918, as Laidlaw has already sug- 
gested.  The presence in human sera of antibodies neutralizing  swine 
influenza virus is believed to indicate a previous immunizing exposure 
to, or infection with, an influenza virus of the 1918 type. 
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